132 related articles for article (PubMed ID: 38159864)
21. M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor.
Lu Y; Wang Y; Wang Y; Wu Y; Huang Y; Liu X; Zhang S; Zhong S; Li Y; Li B; Sun J; Fang S; Zhou H
Thyroid; 2023 Mar; 33(3):338-350. PubMed ID: 36617890
[No Abstract] [Full Text] [Related]
22. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
[TBL] [Abstract][Full Text] [Related]
23. Autophagy is involved in the initiation and progression of Graves' orbitopathy.
Yoon JS; Lee HJ; Chae MK; Lee EJ
Thyroid; 2015 Apr; 25(4):445-54. PubMed ID: 25687157
[TBL] [Abstract][Full Text] [Related]
24. Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
Yang S; Wang X; Xiao W; Xu Z; Ye H; Sha X; Yang H
Front Endocrinol (Lausanne); 2022; 13():891922. PubMed ID: 35663306
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
Ko J; Kim JY; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
[TBL] [Abstract][Full Text] [Related]
26. Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.
Draman MS; Grennan-Jones F; Zhang L; Taylor PN; Tun TK; McDermott J; Moriarty P; Morris D; Lane C; Sreenan S; Dayan C; Ludgate M
Thyroid; 2013 Dec; 23(12):1600-8. PubMed ID: 24001049
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.
Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
PLoS One; 2019; 14(8):e0221077. PubMed ID: 31415657
[TBL] [Abstract][Full Text] [Related]
28. CD40 Enhances Sphingolipids in Orbital Fibroblasts: Potential Role of Sphingosine-1-Phosphate in Inflammatory T-Cell Migration in Graves' Orbitopathy.
Plöhn S; Edelmann B; Japtok L; He X; Hose M; Hansen W; Schuchman EH; Eckstein A; Berchner-Pfannschmidt U
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5391-5397. PubMed ID: 30452592
[TBL] [Abstract][Full Text] [Related]
29. Chemokine Expression during Adipogenesis and Inflammation in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
Lee CE; Choi SH; Yoon JS
Korean J Ophthalmol; 2020 Jun; 34(3):192-202. PubMed ID: 32495527
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves' Orbitopathy.
Kim BR; Kim J; Lee JE; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):39. PubMed ID: 32196098
[TBL] [Abstract][Full Text] [Related]
31. Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
Lee JS; Chae MK; Kikkawa DO; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):51. PubMed ID: 32735324
[TBL] [Abstract][Full Text] [Related]
32. Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves' orbitopathy.
Cao J; Qi X; Wang N; Chen Y; Xie B; Ma C; Chen Z; Xiong W
J Endocrinol Invest; 2023 Oct; 46(10):2005-2016. PubMed ID: 36849849
[TBL] [Abstract][Full Text] [Related]
33. Signal transducer and activator of transcription 3 as a potential therapeutic target for Graves' orbitopathy.
Ko J; Kim JY; Kim BR; Lee EJ; Kikkawa DO; Yoon JS
Mol Cell Endocrinol; 2021 Aug; 534():111363. PubMed ID: 34116129
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Orbital Fibrosis and Adipogenesis by Pathogenic Th17 Cells in Graves Orbitopathy.
Fang S; Huang Y; Zhong S; Li Y; Zhang Y; Li Y; Sun J; Liu X; Wang Y; Zhang S; Xu T; Sun X; Gu P; Li D; Zhou H; Li B; Fan X
J Clin Endocrinol Metab; 2017 Nov; 102(11):4273-4283. PubMed ID: 28938397
[TBL] [Abstract][Full Text] [Related]
36. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.
Virakul S; Somparn P; Pisitkun T; van der Spek PJ; Dalm VASH; Paridaens D; van Hagen PM; Hirankarn N; Palaga T; Dik WA
Front Endocrinol (Lausanne); 2020; 11():619989. PubMed ID: 33658982
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy.
Zhu R; Wang XH; Wang BW; Ouyang X; You YY; Xie HT; Zhang MC; Jiang FG
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108173
[TBL] [Abstract][Full Text] [Related]
38. Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves' ophthalmopathy.
Kim JY; Park S; Lee HJ; Lew H; Kim GJ
Stem Cell Res Ther; 2020 Nov; 11(1):469. PubMed ID: 33153489
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotype of Lacrimal Glands in Graves Orbitopathy: Implications for the Pathogenesis of Th1 and Th17 Immunity.
Huang Y; Wu Y; Zhang S; Lu Y; Wang Y; Liu X; Zhong S; Wang Y; Li Y; Sun J; Fang S; Zhou H
Thyroid; 2022 Aug; 32(8):949-961. PubMed ID: 35469435
[No Abstract] [Full Text] [Related]
40. Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves' Orbitopathy.
Görtz GE; Philipp S; Bruderek K; Jesenek C; Horstmann M; Henning Y; Oeverhaus M; Daser A; Bechrakis NE; Eckstein A; Brandau S; Berchner-Pfannschmidt U
Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36477465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
